HOME : ARCHIVE : Pain Management |
| Electrical
Nerve Stimulation May Help Reduce Bone Pain In Cancer Patients
January 25, 1999 A newly developed electrical nerve-stimulation technique may help alleviate pain associated with cancer that has spread to bones, said researchers at UT Southwestern Medical Center at Dallas. The technique borrows from the ancient practice of Chinese acupuncture. The scientists, writing in December issue of The Clinical Journal of Pain, say their technique, Percutaneous Electrical Nerve Stimulation (PENS), involves the insertion of acupuncture like needles into the soft tissue surrounding bones. This produced significant acute pain relief in patients. During the procedure, a small electrical current is passed through the needles, apparently disrupting normal pain signals by stimulating local nerves. Some cancers that spread to bone (bony metastases) can trigger severe chronic pain that is often unresponsive to analgesic drugs, including morphine. Researchers have found that PENS may reduce the need for narcotics and other more invasive procedures, such as spinal-cord stimulation, by becoming part of an interdisciplinary approach to treating pain associated with certain types of cancers and, eventually, other chronic conditions. "Our goal is to complement, not eliminate, other pain-management techniques by introducing PENS as an integral part of a comprehensive patient-care program," said Dr. Paul White, professor of anesthesiology and pain management at UT Southwestern. "By helping patients avoid the side effects and expense of more invasive procedures, we feel PENS can improve the quality of life of patients suffering from some cancer-related pain. Our research is still very preliminary, but we're very excited about what it suggests and anticipate further success in future clinical trials." In this anecdotal report, which details the cases of three patients treated with PENS, two of the patients  one with prostate cancer and spinal metastases, and the other with rectal cancer with bone involvement  reported a significant reduction in pain after only 30 minutes of stimulation. The treatment failed to provide any marked relief for a third patient with metastatic gallbladder cancer who had no evidence of bone involvement. "Although PENS does not appear to be as effective in treating patients whose cancer has not spread to the bones, we've seen very encouraging results in those with bony metastases," said White. "Pain is such a frustrating element to deal with, for both doctors and patients, which makes these preliminary findings all the more exciting. Any stride we can make in aiding the comfort of our patients, particularly those with terminal diseases, is an important one."
To
contact us or report problems with pages E-mail
January 25, 1999 [email protected] PSA
Rising
Up to topprostate cancer survivor news http://www.psa-rising.com ©2000 |
---|